References
- Hellström-Lindberg E, Malcovati L. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes. Semin Hematol 2008;45:14–22.
- Mannone L, Gardin C, Quarre MC, et al; Groupe Francais des Myelodysplasies. High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome: results of a phase II study. Br J Haematol 2006;133:513–519.
- Jädersten M, Montgomery S, Dybedal I, Porwit-McDonald A, Hellstrom-Lindberg E. Long-term outcome of treatment with granulocyte-CSF and erythropoietin for the anemia of myelodysplastic syndromes. Blood 2005;106:803–811.
- Balleari E, Rossi E, Clavio M, et al Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study. Ann Hematol 2006;85:174–180.
- Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, et al A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol 2003;120:1037–1046.
- Malcovati L, Germing U, Kuendgen A, et al Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007;25:3503–3510.
- Park S, Grabar S, Kelaidi C, et al GFM group (Groupe Francophone des Myélodysplasies). Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience. Blood 2008;111:574–582.
- Jädersten M, Malcovati L, Porwit-McDonald A, Cazzola M, Hellström-Lindberg E. Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need. J Clin Oncol 2008;26:3607–3613.
- Greenberg PL, Sun Z, Miller KB, et al Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). Blood 2009;114:2393–2400.
- Oliva EN, Nobile F, Alimena G, et al Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life. Leuk Lymphoma 2010;51:1007–1014.